IRIS Accounts Production v24.2.0.383 07268416 director 1.9.23 31.8.24 31.8.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072684162023-08-31072684162024-08-31072684162023-09-012024-08-31072684162022-08-31072684162022-09-012023-08-31072684162023-08-3107268416ns15:EnglandWales2023-09-012024-08-3107268416ns14:PoundSterling2023-09-012024-08-3107268416ns10:Director12023-09-012024-08-3107268416ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3107268416ns10:SmallEntities2023-09-012024-08-3107268416ns10:AuditExemptWithAccountantsReport2023-09-012024-08-3107268416ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3107268416ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3107268416ns10:FullAccounts2023-09-012024-08-310726841612023-09-012024-08-3107268416ns10:OrdinaryShareClass12023-09-012024-08-3107268416ns10:CompanySecretary12023-09-012024-08-3107268416ns10:RegisteredOffice2023-09-012024-08-3107268416ns5:CurrentFinancialInstruments2024-08-3107268416ns5:CurrentFinancialInstruments2023-08-3107268416ns5:ShareCapital2024-08-3107268416ns5:ShareCapital2023-08-3107268416ns5:RetainedEarningsAccumulatedLosses2024-08-3107268416ns5:RetainedEarningsAccumulatedLosses2023-08-3107268416ns5:NetGoodwill2023-09-012024-08-3107268416ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3107268416ns5:ComputerEquipment2023-09-012024-08-3107268416ns5:NetGoodwill2023-08-3107268416ns5:NetGoodwill2024-08-3107268416ns5:NetGoodwill2023-08-3107268416ns5:ComputerEquipment2023-08-3107268416ns5:ComputerEquipment2024-08-3107268416ns5:ComputerEquipment2023-08-3107268416ns5:CurrentFinancialInstruments2023-09-012024-08-3107268416ns10:OrdinaryShareClass12024-08-3107268416ns5:RetainedEarningsAccumulatedLosses2023-08-3107268416ns5:RetainedEarningsAccumulatedLosses2023-09-012024-08-31
REGISTERED NUMBER: 07268416 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 August 2024

for

DRUGS TRAINING . COM LIMITED

DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)






Contents of the Financial Statements
FOR THE YEAR ENDED 31 AUGUST 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

DRUGS TRAINING . COM LIMITED

Company Information
FOR THE YEAR ENDED 31 AUGUST 2024







DIRECTOR: L P Watson





SECRETARY: L P Watson





REGISTERED OFFICE: Fiarway House
Links Business Park
St Mellons
Cardiff
CF3 0LT





REGISTERED NUMBER: 07268416 (England and Wales)





ACCOUNTANTS: Hayvenhursts
Fairway House
Links Business Park
St Mellons
Cardiff
CF3 0LT

DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Balance Sheet
31 AUGUST 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 5 - -
Tangible assets 6 3,154 3,942
3,154 3,942

CURRENT ASSETS
Stocks 7 100 400
Cash at bank and in hand 20,729 18,559
20,829 18,959
CREDITORS
Amounts falling due within one year 8 (35,740 ) (34,931 )
NET CURRENT LIABILITIES (14,911 ) (15,972 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(11,757

)

(12,030

)

PROVISIONS FOR LIABILITIES (783 ) (743 )
NET LIABILITIES (12,540 ) (12,773 )

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 10 (12,542 ) (12,775 )
SHAREHOLDERS' FUNDS (12,540 ) (12,773 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Balance Sheet - continued
31 AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 January 2025 and were signed by:





L P Watson - Director


DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 AUGUST 2024

1. STATUTORY INFORMATION

Drugs Training . com Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 AUGUST 2024

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

5. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2023
and 31 August 2024 18,000
AMORTISATION
At 1 September 2023
and 31 August 2024 18,000
NET BOOK VALUE
At 31 August 2024 -
At 31 August 2023 -

DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 AUGUST 2024

6. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 September 2023
and 31 August 2024 10,484
DEPRECIATION
At 1 September 2023 6,542
Charge for year 788
At 31 August 2024 7,330
NET BOOK VALUE
At 31 August 2024 3,154
At 31 August 2023 3,942

7. STOCKS
2024 2023
£    £   
Stocks 100 400

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 109
Tax 17,091 18,128
Social security and other taxes 16,464 14,820
Directors' current accounts 450 224
Accruals and deferred income 1,735 1,650
35,740 34,931

The directors' current account is interest free and repayable on demand.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary 1 2 2

DRUGS TRAINING . COM LIMITED (REGISTERED NUMBER: 07268416)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 AUGUST 2024

10. RESERVES
Retained
earnings
£   

At 1 September 2023 (12,775 )
Profit for the year 60,733
Dividends (60,500 )
At 31 August 2024 (12,542 )

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

At 31 August 2024 an amount of £450 was due to the director. (2023 - £223 ) This amount is interest free and repayable on demand.

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Drugs Training . com Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Drugs Training . com Limited for the year ended 31 August 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Drugs Training . com Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Drugs Training . com Limited and state those matters that we have agreed to state to the director of Drugs Training . com Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Drugs Training . com Limited and its director for our work or for this report.

It is your duty to ensure that Drugs Training . com Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Drugs Training . com Limited. You consider that Drugs Training . com Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Drugs Training . com Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Hayvenhursts
Fairway House
Links Business Park
St Mellons
Cardiff
CF3 0LT


21 January 2025